Evidence map›Paper›PMID 29152406›Full record

ArticleWorld journal of gastrointestinal pharmacology and therapeutics2017

Protozoan parasites in irritable bowel syndrome: A case-control study.

Khaled A Jadallah, Laila F Nimri, Rola A Ghanem

Open access · diamondAbstract read
In one paragraph

Article in World journal of gastrointestinal pharmacology and therapeutics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. The Role ofPathogens (Basel, Switzerland) · 2025
    Review
  4. Blastocystis hominis; Friend or Foe.Integrative medicine (Encinitas, Calif.) · 2024
    Review
  5. Article
  6. Pathogens (Basel, Switzerland) · 2024
    Article
  7. Review
  8. Article
  9. Review
  10. How the gut parasitome affects human health.Therapeutic advances in gastroenterology · 2022
    Review
  11. Enteric Tuft Cells in Host-Parasite Interactions.Pathogens (Basel, Switzerland) · 2021
    Review
  12. Use-case scenarios for an anti-Cryptosporidium therapeutic.PLoS neglected tropical diseases · 2021
    Review
  13. Article
  14. Article
  15. Genetic Diversity and Distribution ofBioMed research international · 2018
    Article
  16. Tropical parasitology
    Review
  17. Molecular characterization ofTropical parasitology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Khaled A JadallahDepartment of Internal Medicine, King Abdullah University Hospital, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan. khaled-j@just.edu.jo.
Laila F NimriDepartment of Medical Laboratory Sciences, Jordan University of Science and Technology, Irbid 22110, Jordan.
Rola A GhanemDepartment of Medical Laboratory Sciences, Jordan University of Science and Technology, Irbid 22110, Jordan.
King Abdullah University Hospital · JOJordan University of Science and Technology · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate the putative role of protozoan parasites in the development of irritable bowel syndrome (IBS).

methodsThe study included 109 IBS consecutive adult patients fulfilling the Rome III criteria and 100 healthy control subjects. All study subjects filled a structured questionnaire, which covered demographic information and clinical data. Fresh stool samples were collected from patients and control subjects and processed within less than 2 h of collection. Iodine wet mounts and Trichrome stained smears prepared from fresh stool and sediment concentrate were microscopically examined for parasites. Blastocystis DNA was detected by polymerase chain reaction, and Cryptosporidium antigens were detected by ELISA.

resultsA total of 109 IBS patients (31 males, 78 females) with a mean age ± SD of 27.25 ± 11.58 years (range: 16 -60 years) were enrolled in the study. The main IBS subtype based on the symptoms of these patients was constipation-predominant (88.7% of patients). A hundred healthy subjects (30 males, 70 females) with a mean ± SD age of 25.0 ± 9.13 years (range 18-66 years) were recruited as controls. In the IBS patients, Blastocystis DNA was detected in 25.7%, Cryptosporidium oocysts were observed in 9.2%, and Giardia cysts were observed in 11%. In the control subjects, Blastocystis, Cryptosporidium and Giardia were detected in 9%, 0%, and 1%, respectively. The difference in the presence of Blastocystis (

conclusionPrevalence of Blastocystis, Cryptosporidium and Giardia is higher in IBS patients than in controls. These parasites are likely to have a role in the pathogenesis of IBS.

Indexed as

BlastocystisCryptosporidiumGiardiaIrritable bowel syndromeProtozoan parasites

Identifiers

PMID29152406
PMCPMC5680167
OpenAlexW2766208521

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.